Evidence map›Paper›PMID 19325075›Full record

ReviewPharmacological reviews2009

Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Alexei Y Bagrov, Joseph I Shapiro, Olga V Fedorova

Open access · greenAbstract readReview
In one paragraph

Review in Pharmacological reviews, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 270 papers.

0numbers the graph read from it
0cells of the map it votes in
270citing papers in PubMed
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

270 citing papers in PubMed, 535 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Steroid hormone ouabain cooperates with NaActa pharmaceutica Sinica. B · 2026
    Article
  7. Review
  8. Exploring the Mechanism of NabioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Cytochrome c and Ouabain Binding Site of Na,K-ATPase.Cell biochemistry and biophysics · 2025
    Article
  16. Review
  17. Article
  18. Review
  19. Antiviral and immunomodulatory effects of ouabain against congenital Zika syndrome model.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  20. Article

210 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alexei Y BagrovLaboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, 5600 Nathan Shock Dr., Baltimore, MD 21224, USA. bagrova@mail.nih.gov
Joseph I Shapiro
Olga V Fedorova
University of Toledo · US

Funding

Sodium pump ligands in blood pressure regulation and profibrotic signaling in hypertension, chronic kidney disease and aging in males and femalesZIAAG000609 · NIA · NATIONAL INSTITUTE ON AGING · PI FEDOROVA, OLGA V · 2009 to 2025
$17.3M
Marinobufagenin as a therapeutic targetZIAAG000869 · NIA · NATIONAL INSTITUTE ON AGING · PI LAKATTA, EDWARD · 2009 to 2025
$14.8M
SODIUM PUMP INHIBITORS IN CARDIOVASCULAR CONTROLZ01AG000609 · NIA · NATIONAL INSTITUTE ON AGING · PI BAGROV, ALEXEI Y · 1993 to 2008
$1.2M
Development of a therapeutic anti-marinobufagenin antibodyZ01AG000869 · NIA · NATIONAL INSTITUTE ON AGING · PI BAGROV, ALEXEI · 2008 to 2008
$467k
Intramural NIH HHS Z01 AG000609Intramural NIH HHS Z01 AG000869
6 · The paper itself

Abstract

Endogenous cardiotonic steroids (CTS), also called digitalis-like factors, have been postulated to play important roles in health and disease for nearly half a century. Recent discoveries, which include the specific identification of endogenous cardenolide (endogenous ouabain) and bufadienolide (marinobufagenin) CTS in humans along with the delineation of an alternative mechanism by which CTS can signal through the Na(+)/K(+)-ATPase, have increased the interest in this field substantially. Although CTS were first considered important in the regulation of renal sodium transport and arterial pressure, more recent work implicates these hormones in the regulation of cell growth, differentiation, apoptosis, and fibrosis, the modulation of immunity and of carbohydrate metabolism, and the control of various central nervous functions and even behavior. This review focuses on the physiological interactions between CTS and other regulatory systems that may be important in the pathophysiology of essential hypertension, preeclampsia, end-stage renal disease, congestive heart failure, and diabetes mellitus. Based on our increasing understanding of the regulation of CTS as well as the molecular mechanisms of these hormone increases, we also discuss potential therapeutic strategies.

Indexed as

AnimalsBlood PressureBufanolidesCardiac GlycosidesCardiotonic AgentsDiabetes MellitusEnzyme InhibitorsFemaleHeart FailureHumansHypertensionOuabainPre-EclampsiaPregnancySignal TransductionSodium-Potassium-Exchanging ATPasebufadienolideBufanolidesCardiac GlycosidesCardiotonic AgentsEnzyme InhibitorsOuabainSodium-Potassium-Exchanging ATPase

Identifiers

PMID19325075
PMCPMC2763610
OpenAlexW2143617499

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.